Preventive screenings

Menopause care and prevention overlap. The same hormonal shift that drives your symptoms also changes your heart, metabolic, and bone health — so ordering and tracking the screenings that live in that overlap is part of your care here. This page shows what's recommended at your age, what we order for you, and what stays with your primary care provider.

Build your screening list

Answer four questions and we'll show which screenings apply to you right now, based on current national guidelines. This is education, not a medical order — we individualize everything at your visits.

I'm currently using estrogen therapy
I've smoked the equivalent of a pack a day for 20+ years and currently smoke, or quit within the last 15 years
I have a bone-risk flag a broken bone from a minor fall as an adult, a parent who fractured a hip, long-term steroid use, or heavy alcohol use

What we order for you

These four overlap directly with menopause care, so we handle the ordering and review the results with you. Message us through your portal when you're ready and we'll send the order to the lab of your choice — locations and lab pricing are in your Member Hub. Tap any row for the evidence behind it.

Lipid panel

Yearly

Measures your cholesterol and triglycerides — the core numbers behind heart health.

Why now: menopause is a cardiometabolic transition. The drop in estrogen shifts lipids, often unfavorably, and cardiovascular risk should be reassessed regularly in women 40–75 — with your full 10-year risk recalculated every 4–6 years to guide decisions like statin use.3,10,11 Female-specific factors — early menopause, preeclampsia, gestational diabetes, autoimmune disease — can upgrade your risk category, so tell us if any apply.11

Blood pressure belongs in this picture too: at least every 2 years if yours runs below 120/80, and yearly from 40 or if it runs higher.3

A1C

Yearly

A three-month average of your blood sugar — the standard screen for prediabetes and diabetes.

Why now: insulin sensitivity often declines through the menopause transition, and diabetes screening is recommended from age 35, repeated at least every 3 years when normal.3,10 We check it yearly so a shift never goes unnoticed between guideline intervals.

Thyroid (TSH)

When symptoms change — ordered anytime

Checks whether your thyroid is over- or under-active.

Why now: thyroid problems and menopause share symptoms — fatigue, mood changes, temperature swings, weight shifts. Checking it means we treat the right cause, not the loudest symptom.

Being honest about the evidence: guidelines actually conflict here. Routine thyroid screening in women with no symptoms isn't recommended by the USPSTF or AAFP, while the American Thyroid Association suggests checking TSH every 5 years from age 35.1,12 Our approach: we don't screen it reflexively — we check it when your symptom picture shifts or doesn't respond the way it should, because that's when the overlap matters.

DEXA (bone density)

At 65 — or earlier if your risk says so

A quick, low-dose scan that measures the strength of your bones at the hip and spine.

Why now: bone loss accelerates in the years around menopause, and it's silent until something breaks. Every woman should have a DEXA at 65 — and earlier if a validated risk tool or a prior low-impact fracture flags elevated risk.7,8 Use the calculator below to see whether earlier testing makes sense for you.

How often it repeats depends entirely on your first result — no sooner than 2 years apart, and a normal baseline may not need rechecking for many years, while advancing osteopenia can warrant yearly follow-up.7

Should you have a DEXA before 65?

The ORAI (Osteoporosis Risk Assessment Instrument) is a validated three-question tool for deciding whether bone density testing makes sense before the standard age.9

Ready to schedule any of these? Message us through your patient portal and we'll send the order. Lab options — where to go and what each costs — are in your Member Hub.

These stay with your PCP

These screenings should stay with your primary care provider for continuity and monitoring — one clinician following your imaging, your results, and your follow-up over the years is what makes them work best. They matter just as much as anything we order, especially on hormone therapy. Tap any row for the current recommendations.

Mammogram

Every 1–2 years from 40

Breast cancer screening starts at 40 for average-risk women — mammography, ideally with tomosynthesis (3D), every 1 to 2 years (yearly per NCCN), continuing to about 74–75.3,4

Higher lifetime risk — strong family history, genetic predisposition, prior chest radiation, dense breasts — can mean starting earlier, screening annually, or adding breast MRI. If any of those apply to you, tell us and your PCP.4 Staying current is part of staying on hormone therapy safely, and up-to-date mammography is part of the baseline assessment before starting it.1

Cervical screening

Every 5 years (HPV-based), 30–65

From 30 to 65, the preferred test is a primary high-risk HPV test every 5 years — including newer self-collected options — with co-testing every 5 years or a Pap every 3 years as alternatives.5,6

Screening can stop at 65 if your prior screening history is adequate and negative — or after a hysterectomy that removed the cervix, with no history of significant precancerous changes. Your PCP can confirm which applies to you.5,6

Colon cancer screening

From 45

Average-risk screening starts at 45. Options include colonoscopy every 10 years, an annual stool test (FIT), stool DNA every 1–3 years, or CT colonography or sigmoidoscopy every 5 years — continuing to 75, then selectively to 85.3

The best test is the one that actually gets done — if a colonoscopy keeps getting postponed, ask your PCP about the stool-based options.

Lung cancer screening

Yearly, 50–80, if you qualify

An annual low-dose CT is recommended from 50 to 80 for anyone with a 20+ pack-year smoking history who currently smokes or quit within the last 15 years.3

A pack-year is one pack a day for one year — so half a pack a day for 40 years counts too. If this might be you, it's worth one conversation with your PCP.

Mood, and a few one-time tests

Ongoing / once

Perimenopause carries a genuinely elevated risk of mood disorders — depression screening is recommended for all women, and anxiety screening under 65.3 Your symptom tracker already watches this with us; if your mood shifts, that's a message-us-now item, not a wait-for-the-next-check item.

One-time tests worth confirming you've had: HIV (at least once before 65), hepatitis C (once, ages 18–79), and hepatitis B (once for everyone). And a fact worth knowing: STI rates are currently rising fastest in women 55–64 — if your situation warrants it, testing is nothing to be shy about.3

Why there's no "hormone panel" on this page

For women over 45, menopause is diagnosed clinically — by your age, your cycle pattern, and your symptoms. FSH and estradiol levels should not be used to diagnose menopause, adjust estrogen dosing, or predict where you are in the transition; they swing too much to be meaningful. Hormone testing has a real role only in narrower situations: women 40–45 with symptoms and irregular cycles, or under 40 when premature ovarian insufficiency is suspected.1,2 So if you've been told you "need labs to confirm menopause" — you don't, and we'd rather spend your money on the screenings above. When hormone labs do have a job — and how we use them in your care — the full guide is here: Hormone labs, explained.

References

  1. Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023.
  2. Ortmann O, Beckermann MJ, Inwald EC, et al. Peri- and postmenopause — diagnosis and interventions: interdisciplinary S3 guideline (AWMF 015/062). Arch Gynecol Obstet. 2020.
  3. Plesa M, Wong A, Katsaggelos E. Health Maintenance in Postmenopausal Women. Am Fam Physician. 2025.
  4. National Comprehensive Cancer Network. Breast Cancer Screening and Diagnosis. NCCN Guidelines, updated 2026.
  5. ACOG Committee on Clinical Consensus–Gynecology. Screening for Cervical Cancer. Obstet Gynecol. 2026.
  6. Women's Preventive Services Initiative. Screening for Cervical Cancer: A Recommendation. Obstet Gynecol. 2026.
  7. ACOG Committee on Clinical Practice Guidelines–Gynecology. Osteoporosis Prevention, Screening, and Diagnosis: Clinical Practice Guideline No. 1. Obstet Gynecol. 2021.
  8. US Preventive Services Task Force. Screening for Osteoporosis to Prevent Fractures: Recommendation Statement. JAMA. 2018.
  9. Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000.
  10. Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022.
  11. El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association. Circulation. 2020.
  12. Screening for Thyroid Disease: Recommendation Statement. Am Fam Physician. 2004.
  13. Walker MD, Shane E. Postmenopausal Osteoporosis. N Engl J Med. 2023.
This page is education for our members, not individual medical advice. Your screening plan is personalized at your visits based on your history and risk factors.